Work

P-592 Neoadjuvant chemo- and radiotherapy in stage IIIA (N2) non-small cell lung cancer (NSCLC). Rationale for a radomized trial by the swiss group for clinical cancer research (SAKK)

Year: 2003

Type: conference-abstract

Source: Lung Cancer

DOI: 10.1016/s0169-5002(03)92559-1

Authors: Miklos Pless, Rolf Stahel, Sabine Balmer-Majno, Roger Stupp, Daniel Betticher, Franz Egli, Kaspar Rufibach, Sandra Thierstein, Hans-Beat Ris, Rene-Olivier Mirimanoff

Language: English

Topic: Lung Cancer Diagnosis and Treatment

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2011976863

Cites:

Cited by:

Related to: 10